Prevalence of Hyperacusis and Its Relation to Health: The Busselton Healthy Ageing Study.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
12 2021
Historique:
revised: 04 07 2021
received: 13 10 2020
accepted: 13 07 2021
pubmed: 23 7 2021
medline: 25 11 2021
entrez: 22 7 2021
Statut: ppublish

Résumé

The prevalence of hyperacusis and its relationship with mental and general health is unknown in a nonclinical sample. Therefore, we aimed to determine the prevalence of hyperacusis and its relation with hearing, general and mental health in a population-based study. Prospective population-based study. This study uses data from the Busselton Healthy Ageing Study (BHAS). A sample of 5,107 eligible inhabitants aged 45 to 70 years completed a detailed questionnaire and a clinical assessment. A positive answer to "Do you consider yourself sensitive or intolerant to everyday sounds" was used to indicate hyperacusis. Logistic regression was used to examine the association between hearing, mental and general health factors, and hyperacusis. Of 5,107 participants, 775 (15.2%) reported hyperacusis. The majority of participants with hyperacusis reported an occasional effect on daily life (72.0%). Being female, older in age, having a lower income, physical or mental health difficulties, more severe hearing loss, and tinnitus were all associated with the presence of hyperacusis. Individuals who experience hearing impairment, poorer general or mental health have a higher possibility of hyperacusis having an effect on their daily life. In this community population-based cohort study, we found a prevalence of hyperacusis of 15.2%. Individuals with hearing loss, mental health problems, and lower physical health have a higher possibility of experiencing effects on their daily life associated with their hyperacusis. Unravelling the relationship between hyperacusis hearing, general and mental health can be of major importance for a better understanding of the condition and its consequences. 2 Laryngoscope, 131:E2887-E2896, 2021.

Identifiants

pubmed: 34291459
doi: 10.1002/lary.29768
pmc: PMC9292021
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

E2887-E2896

Subventions

Organisme : City of Busselton
Organisme : Government of Western Australia (Office of Science, Department of Health)
Organisme : private donations
Organisme : UK National Institute for Health Research

Informations de copyright

© 2021 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Références

BMJ. 2006 May 6;332(7549):1080
pubmed: 16675816
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
BMC Med Res Methodol. 2016 May 18;16:54
pubmed: 27193095
Int J Audiol. 2013 Apr;52(4):230-5
pubmed: 23244506
J R Soc Med. 2003 Dec;96(12):582-5
pubmed: 14645606
Eur J Public Health. 2013 Feb;23(1):146-52
pubmed: 22197756
PLoS One. 2017 Nov 21;12(11):e0188255
pubmed: 29161302
Braz J Otorhinolaryngol. 2014 Jan-Feb;80(1):24-8
pubmed: 24626888
J Epidemiol. 2014;24(2):161-7
pubmed: 24317343
Brain Struct Funct. 2014 May;219(3):1113-28
pubmed: 23609486
BMJ Open. 2016 Jun 03;6(6):e010596
pubmed: 27259524
HNO. 2018 May;66(5):358-363
pubmed: 29392341
PLoS One. 2014 Jan 31;9(1):e86944
pubmed: 24498000
Int J Audiol. 2002 Dec;41(8):545-54
pubmed: 12477175
Neuroscience. 2019 May 21;407:1-7
pubmed: 30885639
Front Med (Lausanne). 2020 Oct 15;7:562963
pubmed: 33178712
Noise Health. 2016 Jul-Aug;18(83):178-84
pubmed: 27569405
Biomed Res Int. 2017;2017:2723715
pubmed: 29312994
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Lancet. 2019 Feb 2;393(10170):404-405
pubmed: 30722956
J Neurosci. 2013 Feb 6;33(6):2356-64
pubmed: 23392665
BMC Public Health. 2013 Oct 08;13:936
pubmed: 24099269
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131

Auteurs

Adriana L Smit (AL)

Department of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.

Inge Stegeman (I)

Department of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.

Robert H Eikelboom (RH)

Ear Sciences Centre, The University of Western Australia, Nedlands, Australia.
Department of Speech Language Pathology and Audiology, University of Pretoria, Pretoria, South Africa.
Ear Science Institute Australia, Subiaco, Australia.

David M Baguley (DM)

Hearing Sciences, Division of Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, U.K.
NIHR Nottingham Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, U.K.

Rebecca J Bennett (RJ)

Ear Sciences Centre, The University of Western Australia, Nedlands, Australia.
Ear Science Institute Australia, Subiaco, Australia.

Susan Tegg-Quinn (S)

Ear Sciences Centre, The University of Western Australia, Nedlands, Australia.
Ear Science Institute Australia, Subiaco, Australia.
School of Human Sciences, The University of Western Australia, Perth, Australia.

Romola S Bucks (RS)

School of Psychological Science, The University of Western Australia, Perth, Australia.

Robert J Stokroos (RJ)

Department of Otorhinolaryngology and Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.

Michael Hunter (M)

Busselton Health Study Centre, Busselton Population Medical Research Institute, Perth, Australia.
School of Population and Global Health, University of Western Australia, Perth, Australia.

Marcus D Atlas (MD)

Ear Sciences Centre, The University of Western Australia, Nedlands, Australia.
Ear Science Institute Australia, Subiaco, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH